Related Experiment Video
Updated: May 22, 2025

16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
25.9K
Imaging and neuromodulation in Parkinson's disease
Alexandre Boutet1,2,3, Jürgen Germann3,4,5, Alfonso Fasano6,7
1Joint Department of Medical Imaging, University of Toronto.
Current Opinion in Neurology
|May 21, 2025
Summary
Advanced imaging enhances deep brain stimulation (DBS) for Parkinson's disease by personalizing electrode placement and optimizing stimulation. This improves patient outcomes and guides future neuromodulation strategies.
Area of Science:
- Neuromodulation
- Neurosurgery
- Radiology
Background:
- Deep brain stimulation (DBS) is a primary neuromodulatory treatment for Parkinson's disease.
- Advancements in neuroradiological techniques are expanding the role of imaging in DBS.
Purpose of the Study:
- To review the expanding role of imaging in neuromodulation for Parkinson's disease, particularly DBS.
- To highlight how imaging informs patient selection, electrode placement, and outcome prediction.
Main Methods:
- Review of current and emerging neuroradiological techniques in DBS.
- Analysis of imaging's role across pre-, intra-, and postoperative phases of DBS care.
Main Results:
- Imaging is essential for patient selection and precise, individualized electrode implantation.
- Fluoroscopy enables intra-operative lead localization, and advanced techniques identify optimal anatomical targets and connectomes.
- Imaging aids in developing biomarkers for successful stimulation and programming.
Conclusions:
- Imaging is a powerful tool for personalized electrode implantation and stimulation titration in DBS.
- It improves patient outcomes and informs the development of alternative neuromodulation techniques.
Related Concept Videos
Parkinson's Disease: Treatment
170
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
170
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
Brain Imaging
199
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
199

